Optimise early phase clinical studies, generate certainty & secure the most favourable path to market
We offer expert partnering and consultation to ensure your early phase clinical studies and development strategy incorporates modern best practices to effectively generate data that will satisfy all external decision makers and your commercialization targets. Our services build confidence that your early phase studies and program will reliably and effectively meet your vital clinical development needsMORE ABOUT US
What we Offer
Customized solutions for early phase clinical study design and clinical development strategy
When you access Armstrong Clinical you leverage the expertise of professionals in Early Phase Study Design, Translational Medicine, Phase I-IV development strategy, pricing and market access and study implementation. Before your first study begins, define your path to market with early phase study design that assure subsequent clinical development decisions
Clinical Development: Path to Market
Before your studies begin, we help you define the regulatory strategy, clinical study requirements, commercial expectation cost and time requirements at each stage of development. This allows for effective decision making and and a clear path to market
Phase I and IIa Study Designs
We work with you to design or review your planned early phase clinical studies. Our experience designing simple to modern, complex early phase studies will help taylor a design to suit your therapy, indication and company objectives.
Study Location and CRO Selection
Looking to conduct your early phase in Australia? It’s important the CRO and Clinical Site best suited to your organisation, disease are and project. is selected. We can help advise where best to conduct your early phase study and with who.
Clinical Development of Today
Tools and techniques of study design and development strategy are evolving rapidly to generate more efficient studies, programs and precision outcomes. Understand when and how complex adaptive designs, predictive modelling, etc. can be utilised to create precision and reduce your development time and cost.
What we bring to the table
We add value across the clinical development lifecycle from Phase I studies through to Phase IV. Some key skills that our team brings to the table include:
SOUND REGULATORY INSIGHTS
TRIAL PLANNING & DESIGN
GATED TARGET PLANNING
EXECUTION & LOCATION ADVICE
WRITING, PUBLISHING & SUBMISSIONS
Don’t take our word for it – here’s what our clients say:
“Our engagement with Armstrong Clinical has been extremely valuable. The advice was pragmatic and provided us with a range of options based on our objectives, timelines and budget. The stage-gated approach to developing our clinical development strategy provided clarity and metrics that are unique to our program and will guide our decision-making process.”
Dr Rachel de las Heras – Program Director
Queensland Brain Institute, University of Queensland
“Armstrong Clinical provided top-notch assistance with our clinical development program. Their advice regarding our early phase clinical trial helped us meet our development timelines.”
John – Sr. Director
Large Multinational Pharma
Latest Blog Posts
At Armstrong Clinical we are committed to providing our audience latest information about various aspects of clinical development, especially as it applies in the Australian context.
If you need any information about our services and how our team can add value to your project, please feel free to contact us. We would be glad to discuss further.Click Here for Contact Details